Wiley Bros. Aintree Capital, LLC Pfizer Inc Transaction History
Wiley Bros. Aintree Capital, LLC
- $718 Million
- Q1 2024
A detailed history of Wiley Bros. Aintree Capital, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Wiley Bros. Aintree Capital, LLC holds 76,789 shares of PFE stock, worth $2.14 Million. This represents 0.3% of its overall portfolio holdings.
Number of Shares
76,789
Previous 54,346
41.3%
Holding current value
$2.14 Million
Previous $1.56 Million
36.19%
% of portfolio
0.3%
Previous 0.38%
Shares
13 transactions
Others Institutions Holding PFE
# of Institutions
3,158Shares Held
3.68BCall Options Held
67.4MPut Options Held
113M-
Vanguard Group Inc Valley Forge, PA507MShares$14.1 Billion0.28% of portfolio
-
Black Rock Inc. New York, NY431MShares$12 Billion0.28% of portfolio
-
State Street Corp Boston, MA291MShares$8.09 Billion0.37% of portfolio
-
Wellington Management Group LLP Boston, MA178MShares$4.95 Billion0.89% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA122MShares$3.4 Billion0.79% of portfolio
About PFIZER INC
- Ticker PFE
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 5,612,349,952
- Market Cap $156B
- Description
- Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...